Clinical Benefit of Comprehensive Genomic Profiling for Advanced Cancers in India.

Aju MathewSerena JosephJeffrey BobySteve BennyJaneesh VeeduSenthil RajappaNitesh RohatgiBhawna SirohiReetu JainVivek Agarwala Deepak Kumar Shukla Anurag Mehta Raja Pramanik Vineet TalwarVinayak MakaNirmal Raut

Published in: JCO global oncology (2022)

We observed that in a low-middle-income country setting, 10% of patients received targeted therapy on the basis of CGP assay. Only 4% of patients who underwent CGP testing obtained a clinical benefit.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
mental health